P.O. Box 10307
New Orleans, LA 70181
(504) 888-8255
COMMENTARY OF THE DAY
By
Robert Namer
Voice Of America
©2020 All rights reserved
May 21, 2020

     Cavuto is causing his own ouster from Fox News. For two days running, Neil Cavuto has warned that a drug taken by President Trump, hydroxychloroquine, carries risks. Some of his colleagues disagree.  In a dust-up between the top-rated cable news channel and its most prominent loyal viewer, Mr. Trump unleashed a barrage against the Fox News anchor Neil Cavuto, who gave a withering on-air assessment of the president’s announcement that he was ingesting hydroxychloroquine, a malaria drug that can pose dangers for coronavirus patients. “.@FoxNews is no longer the same,” Mr. Trump lamented on Twitter. Invoking the name of Fox News’s late founder, the president added: “We miss the great Roger Ailes. You have more anti-Trump people, by far, than ever before. Looking for a new outlet!”

     By Tuesday morning, the president had apparently warmed to the network again, congratulating the morning show “Fox & Friends” on its high ratings. But the fissure underscored Mr. Trump’s keen sensitivity to any hint of criticism from his preferred TV network, where star pundits like Sean Hannity and Steve Doocy have made prime-time and morning shows into pro-Trump cheering platforms.

     Hydroxychloroquine was already a fraught subject at Fox News. The prime-time host Laura Ingraham has relentlessly promoted the drug as a potential cure for the coronavirus, even pitching Mr. Trump in person in the Oval Office. But many medical experts, including those at the Food and Drug Administration, have warned against its use to treat the disease, citing a risk of serious heart problems.

     On Monday, Mr. Cavuto was hosting his 4 p.m. show when Mr. Trump told reporters at the White House that he had begun taking hydroxychloroquine as a preventive measure against the coronavirus. When the camera cut to Mr. Cavuto, the anchor looked stricken.

News Gathering & Commentary © 2020 Hot Talk Radio, all rights reserved